Is Endo Pharmaceuticals still in business?
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system….Endo International.
| Type | public liability company |
|---|---|
| Traded as | Nasdaq: ENDP S&P 600 component |
| ISIN | IE00BJ3V9050 |
| Industry | Pharmaceutical |
Who owns Endo Pharmaceuticals?
Endo markets its products to primary care physicians and specialists, as well as to other healthcare professionals and retail pharmacies. The company is 60 percent owned by investment firm Kelso & Company.
Why is ENDP down?
Related Stocks Shares of Endo International (NASDAQ:ENDP) came in crashing after The Wall Street Journal reported that the drugmaker had engaged Alvarez & Marsal to look into a potential financial restructuring. Price Action: ENDP shares are down 35.7% at $2.29 during the market session on the last check Friday.
Is Endo International a good stock to buy?
Endo International currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period..
Who bought Par Pharmaceuticals?
Endo International plc
Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Par Pharmaceutical Holdings, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion , including assumption of Par debt.
Is Endo Pharmaceuticals a good company to work for?
On average, employees at Endo Pharmaceuticals give their company a 4.0 rating out of 5.0 – which is 3% higher than the average rating for all companies on CareerBliss. The happiest Endo Pharmaceuticals employees are Pharmaceutical Sales Representatives submitting an average rating of 2.7.
Is Endo aesthetics a public company?
Endo Pharmaceuticals acquired Algos Pharmaceutical Corporation through a merger. As a result of this merger, Endo Pharmaceuticals became a publicly traded company, under the NASDAQ symbol ENDP.
Where is Endo International located?
Malvern, Pennsylvania
Endo has global headquarters in Dublin, Ireland and its U.S. corporate office in Malvern, Pennsylvania.
Is Endo a buy?
Endo International currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
What is MKGI?
MGI. Moneygram International, Inc. 6.92. Financial Services. Stocks.
Is Endo a good investment?
Endo International plc – Hold Valuation metrics show that Endo International plc may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of ENDP, demonstrate its potential to outperform the market. It currently has a Growth Score of B.
Is Endo Pharmaceuticals a buy?
Endo International has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.